Swiss watch and jewelry giant Swatch Group reported a steep decline in full-year profit and revenue, with pre-tax earnings nearly halved as consumer demand softened and operational costs climbed.
Meritage Homes shares have lagged peers over the past year, but a detailed valuation analysis suggests a significant gap between its current price and estimated intrinsic value. We examine the DCF and P/E metrics fueling the debate.
Buoyed by a banner 2025 and surging consumer appetite for ocean voyages, Royal Caribbean Group forecasts double-digit profit growth for 2026, signaling a full-throttle recovery for the cruise industry.
A growing list of casual dining chains are turning to bankruptcy court and closing underperforming stores as heavy debt loads and shifting consumer habits take their toll. The latest casualty, FAT Brands, has moved to permanently close 32 locations and reject their leases.
Once left for dead after a 95% stock collapse, Jumia Technologies AG is staging a remarkable comeback. A locally-focused strategy, a vast pickup station network, and a blockbuster Black Friday in Lagos signal the African e-commerce pioneer may finally be on a path to sustainable growth, even as it faces competition from global giants.
LendingClub Corporation (NYSE: LC), having transformed into a hybrid digital bank and marketplace, is drawing investor attention for its dual revenue streams and strategic pivot post-Radius Bank acquisition. With shares trading around $16.44 and a forward P/E of 9.64, bulls argue its unique structure positions it for steadier growth in a volatile market.
Greg Abel's first major move as Berkshire Hathaway CEO involves reviewing a full exit from the Kraft Heinz stake, marking a potential departure from Warren Buffett's famed 'buy and hold' philosophy and testing investor confidence in the new leadership era.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
SanDisk (NASDAQ: SNDK) and Kioxia have renewed their flash memory joint venture for another five years, a strategic move aimed at securing advanced 3D NAND production capacity and supply chains through 2034 to meet the explosive storage needs of artificial intelligence.
India's latest budget outlines a massive strategic pivot, channeling over $10 billion into domestic rare earths processing and clean energy. The move aims to secure critical mineral supply chains and boost nuclear power, reducing reliance on foreign sources, particularly China.
Facing rising churn and fierce competition, Verizon's new leadership is pivoting from unpopular price hikes to a customer-centric strategy, leveraging AI and convergence to rebuild trust and retain subscribers.
Amid market volatility, a deep dive into Broadridge Financial Solutions (BR) reveals a compelling investment case built on its near-monopoly in critical back-office functions, predictable cash flows, and defensive characteristics.
As Ford Motor Company takes a massive charge on its electric vehicle business, a bullish investment thesis is gaining traction, arguing the automaker's strategic shift toward hybrids and profitable segments could unlock long-term value.
Amid a cautious retail environment, Ollie's Bargain Outlet (OLLI) is posting impressive growth by leaning into aggressive pricing and rapid store expansion. Its latest earnings beat and a fortified loyalty program are painting a compelling picture for long-term investors, even as valuation questions linger.
Avery Dennison (AVY), the often-overlooked materials science giant, is drawing investor attention with its pivot to high-margin digital identification solutions and a rock-solid financial profile. With intelligent labels driving growth and a dividend that has increased for 15 consecutive years, the company presents a case for resilient, innovation-led expansion.
ResMed Inc., the sleep therapy giant, faces a pivotal moment. While benefiting from a competitor's recall and a growing market funnel, emerging oral treatments and shifting dynamics pose fresh challenges to its long-held CPAP business model.
A detailed investment thesis argues that fintech firm Sezzle Inc., having successfully shifted to a subscription model, presents a compelling opportunity through a specific options strategy that capitalizes on lingering market fears and undervalued long-term volatility.
Ziff Davis (ZD) shares are attracting value investors with a seemingly cheap valuation and potential asset sales. However, underlying concerns about revenue quality, customer churn, and existential threats from AI-driven search shifts paint a more complex picture for the digital media conglomerate.
Amidst market frenzy for AI, a bullish case is building for Vital Farms. Analysts highlight its premium brand resilience, predictable growth, and surprising insulation from the egg price swings that hammer competitors.
A significant institutional options trade on Abbott Laboratories (ABT) signals strong confidence in the healthcare giant's legal resilience and valuation floor, presenting a unique risk/reward opportunity for investors.
